MetinOzdemirliMD
Pathology • Washington, DCHematopathology, Anatomic Pathology, Clinical Pathology
Professor, Pathology, Georgetown University Hospital
Are you Dr. Ozdemirli?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3800 Reservoir Rd Nw
Washington, DC 20007Phone+1 202-444-3614
Summary
- Dr. Metin Ozdemirli, MD is a board certified pathologist in Washington, District of Columbia. He is currently licensed to practice medicine in District of Columbia and Maryland. He is a Professor at Georgetown University Hospital.
Education & Training
Boston University School of MedicineClass of 1993
Certifications & Licensure
DC State Medical License 1995 - 2027
MD State Medical License 2023 - 2025
American Board of Pathology Anatomic Pathology- American Board of Pathology Hematology
Publications & Presentations
PubMed
- Chronic endothelial inflammation in PWH leads to reduced circulating megakaryocyte progenitor cells.Tong Li, Colleen Hadigan, Jaeil Ahn, Chinmayee Mehta, Makheni Jean Pierre
Blood Vessels, Thrombosis & Hemostasis. 2025-02-01 - Pediatric monomorphic post-transplant lymphoproliferative disorder with plasmablastic differentiation: A challenge for diagnosis and treatment.Jinjun Cheng, Sarah Harney, Keri Toner, Paige Kube, Shunyou Gong
Pediatric Blood & Cancer. 2024-08-01 - 12 citationsIndolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy.Metin Ozdemirli, Thomas M Loughney, Emre Deniz, Joeffrey J Chahine, Maher Albitar
The New England Journal of Medicine. 2024-06-13
Press Mentions
Case Study Reveals Important New Details About Rare Second Cancers Related to CAR-T TherapyJune 13th, 2024- Tragic New Details About Dozens of American Patients Whose Life-Saving Cancer Treatment Caused Them to Develop More CancersJune 13th, 2024
- Immunotherapy to Treat Cancer Gave Rise to 2nd Cancer in Extremely Rare CaseJune 14th, 2024
- Join now to see all
